Numab and 3SBio’s Sunshine Guojian Expand Partnership to Develop Novel T Cell Engager NM28
WÄDENSWIL, Switzerland, SHENYANG, China, & SHANGHAI--(BUSINESS WIRE)--Numab Therapeutics AG (Numab) and 3SBio Inc. (“3SBio”, HKEX:1530) announced today that 3SBio’s subsidiary...







